Outlook Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OTLK and other ETFs, options, and stocks.About OTLK
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF.
OTLK Key Statistics
Stock Snapshot
As of today, Outlook Therapeutics(OTLK) shares are valued at $0.26. The company's market cap stands at 26.46M, with a P/E ratio of -0.23.
As of 2026-04-15, Outlook Therapeutics(OTLK) stock has fluctuated between $0.24 and $0.26. The current price stands at $0.26, placing the stock +5.2% above today's low and -3.6% off the high.
The Outlook Therapeutics(OTLK)'s current trading volume is 2.65M, compared to an average daily volume of 4.64M.
During the past year, Outlook Therapeutics(OTLK) stock moved between $0.16 at its lowest and $3.39 at its peak.
During the past year, Outlook Therapeutics(OTLK) stock moved between $0.16 at its lowest and $3.39 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.